APPLICATION
ANDA209406
TYPE
ANDA
ORIGINAL APPROVAL
2020-11-27
LATEST ACTION
2024-06-17
ROUTE
OPHTHALMIC
DOSAGE FORM
SUSPENSION/DROPS
MARKETING STATUS
Prescription
Products
BRINZOLAMIDEPrescription
BRINZOLAMIDE 1% · SUSPENSION/DROPS · OPHTHALMIC
Approval history
2024-06-17Labeling · Supplement 4 · standardAP
2022-12-20Labeling · Supplement 1 · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.